Cubist Systematic Strategies’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Cubist Systematic Strategies’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-27,235	Closed	-$45K	–	4903
2022 Q2	$45K	Buy	27,235 +16,087	+144%	+$33.4K	﹤0.01%	4114
2022 Q1	$33K	Sell	11,148 -50,333	-82%	-$176K	﹤0.01%	3431
2021 Q4	$294K	Buy	+61,481	New	+$397K	﹤0.01%	2812
2021 Q3	–	Sell	-66,400	Closed	-$495K	–	3253
2021 Q2	$495K	Sell	66,400 -97,155	-59%	-$749K	0.01%	2018
2021 Q1	$1.28M	Buy	163,555 +98,188	+150%	+$981K	0.02%	1371
2020 Q4	$604K	Buy	65,367 +60,311	+1,193%	+$524K	0.01%	1675
2020 Q3	$35K	Buy	+5,056	New	+$30.7K	﹤0.01%	2387

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Cubist Systematic Strategies's SURF Position: Q3 2022 in Review

Cubist Systematic Strategies sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2022, closing a stake of 27,235 shares — an estimated $45K sold.

Cubist Systematic Strategies first reported a position in SURF in Q3 2020 and held it in 7 quarters. The position peaked at $1.28M in Q1 2021. 79 funds tracked by Wall St. Rank hold SURF as of Q3 2022.

Cubist Systematic Strategies reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Cubist Systematic Strategies sold 27,235 Surface Oncology, Inc. Common Stock shares in Q3 2022, an estimated $45K.
Cubist Systematic Strategies first reported a position in Surface Oncology, Inc. Common Stock in Q3 2020 and held it in 7 quarters.
Cubist Systematic Strategies's Surface Oncology, Inc. Common Stock position peaked at $1.28M in Q1 2021.
79 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2022.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.